
Current Price | $73.54 | Mkt Cap | $1.5B |
---|---|---|---|
Open | $73.23 | P/E Ratio | 138.49 |
Prev. Close | $73.41 | Div. (Yield) | $0.24 (0.3%) |
Daily Range | $71.73 - $73.66 | Volume | 30,634 |
52-Wk Range | $26.00 - $83.78 | Avg. Daily Vol. | 233,584 |
The Company currently offers four software products for pharmaceutical research: ADMET Predictor/ ADMET Modeler, ClassPharmer, DDDPlus, and GastroPlus.
Current Price | $73.54 | Mkt Cap | $1.5B |
---|---|---|---|
Open | $73.23 | P/E Ratio | 138.49 |
Prev. Close | $73.41 | Div. (Yield) | $0.24 (0.3%) |
Daily Range | $71.73 - $73.66 | Volume | 30,634 |
52-Wk Range | $26.00 - $83.78 | Avg. Daily Vol. | 233,584 |
The best Bull and Bear pitches based on recency and number of recommendations.
Market overestimating the addressable market of their product. Valuation can only be justified if historical growth rates are sustained for a significant period of time, but these growth rates are clearly unsustainble.
Read the most recent pitches from players about SLP.
Recs
Just tracking
Recs
Feroldi....similar to SDGR but more drug development and high margin consulting
Recs
Stuck with amazing proprietary software that cannot be moved to cloud, however diversified revenue through addition of services and digitizing their process. Very promising. Strong balance sheet.
Find the members with the highest scoring picks in SLP.
eversuhoshin (78.38) Score: +3,540.71
The Score Leader is the player with the highest score across all their picks in SLP.
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
---|---|---|---|---|---|---|---|---|---|---|
eversuhoshin | 78.38 | 7/9/2010 |
![]() |
5Y | $1.89 | +3,798.22% | +257.51% | +3,540.71 | 0 Comment | |
marc021248 | 34.26 | 7/20/2010 |
![]() |
5Y | $1.96 | +3,655.87% | +259.79% | +3,396.08 | 0 Comment | |
alley11 | 24.82 | 7/8/2010 |
![]() |
5Y | $1.98 | +3,610.77% | +257.94% | +3,352.82 | 0 Comment | |
browns31 | < 20 | 7/14/2010 |
![]() |
1Y | $1.99 | +3,595.66% | +250.67% | +3,344.99 | 1 Comment | |
Southoftheborder | 61.05 |
|
![]() |
5Y | $2.09 | +3,426.08% | +207.90% | +3,218.18 | 0 Comment | |
Pepe150 | < 20 | 1/12/2011 |
![]() |
1Y | $2.19 | +3,259.68% | +198.73% | +3,060.95 | 1 Comment | |
pureoncharts | 51.38 | 1/18/2011 |
![]() |
3W | $2.33 | +3,054.06% | +196.49% | +2,857.57 | 0 Comment | |
stratisticalarb | 23.61 | 5/6/2011 |
![]() |
1Y | $2.34 | +3,042.47% | +185.29% | +2,857.18 | 0 Comment | |
kitenio | 94.55 | 11/3/2010 |
![]() |
1Y | $2.44 | +2,909.49% | +220.41% | +2,689.09 | 0 Comment | |
anguijm | 79.90 | 4/25/2011 |
![]() |
5Y | $2.55 | +2,778.39% | +186.51% | +2,591.89 | 1 Comment |
See what the Wall Street professionals think, according to their public statements and filings.